Fredun Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 539730 | NSE: | Pharmaceuticals & Drugs | Small Cap

Fredun Pharma Share Price

871.10 0.75 0.09%
as on 18-May'24 12:50

DeciZen - make an informed investing decision on Fredun Pharma

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Fredun Pharmaceuticals stock performance -

mw4me loader
P/E Ratio (SA):
26.61
Market Cap:
415.7 Cr.
52-wk low:
650
52-wk high:
1,249

Is Fredun Pharmaceuticals Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Fredun Pharma: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Fredun Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 18.9%9.4%15.7%9.5%10.5%15%7.3%6.3%8.7%11.3%-
Value Creation
Index
0.4-0.30.1-0.3-0.30.1-0.5-0.6-0.4-0.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 21.325.342.356.759.697113134224275347
Sales YoY Gr.-19%67.1%34%5%62.9%16.2%18.7%67.7%22.4%-
Adj EPS 4.61.34.43.54.911.54.44.912.421.733.1
YoY Gr.--71.5%238.9%-20.7%38.4%136.6%-62.2%13.3%151.6%74.6%-
BVPS (₹) 1111.515.720.164.797.7103.6108153.1194.3261.5
Adj Net
Profit
1.10.31.10.81.74.61.725.59.816
Cash Flow from Ops. -0.71.83.3417.30.8-10.60.2-2.4-14.4-
Debt/CF from Ops. -10.45.14.74.60.623.1-3.3233.3-22.2-6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 32.9%35.8%34.6%22.4%
Adj EPS 18.8%34.8%70.7%74.6%
BVPS37.6%24.6%23.3%26.9%
Share Price - 15% 26% -3.3%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
39.310.429.714.811.3154.34.79.91214.5
Op. Profit
Mgn %
12.36.79.869.610.57.476.210.511.2
Net Profit
Mgn %
5.11.22.51.52.84.71.51.52.53.64.5
Debt to
Equity
2.53.13.92.50.50.50.80.90.810
Working Cap
Days
155167174200261230290324230244114
Cash Conv.
Cycle
16182812-31159811110013540

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Fredun Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 33.1 -
TTM Sales (₹ Cr.) 347 -
BVPS (₹.) 261.5 -
Reserves (₹ Cr.) 119 -
P/BV 3.37 -
PE 26.61 -
From the Market
52 Week Low / High (₹) 650.00 / 1249.00
All Time Low / High (₹) 12.50 / 1428.00
Market Cap (₹ Cr.) 416
Equity (₹ Cr.) 4.7
Face Value (₹) 10
Industry PE 48.1

Management X-Ray of Fredun Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Fredun Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales212542576097113134224275
Operating Expenses 202438535487104125211246
Manufacturing Costs4211173776811
Material Costs10151925406082102177209
Employee Cost 334558991112
Other Costs 3457612781515
Operating Profit 1243610891429
Operating Profit Margin (%) 6.7%6.5%9.2%5.9%9.6%10.3%7.4%7.0%6.2%10.5%
Other Income 0012011122
Interest 11222344510
Depreciation 1111112223
Exceptional Items 0000000-100
Profit Before Tax 01223623918
Tax 0011121127
Profit After Tax 00112422611
PAT Margin (%) 1.1%1.0%2.5%2.5%2.9%4.6%1.7%1.5%2.8%3.9%
Adjusted EPS (₹)0.91.14.55.44.211.24.85.114.323.8
Dividend Payout Ratio (%)0%0%13%11%14%6%14%14%5%3%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 3347223941436888
Share Capital 3335344445
Reserves 0012193537396384
Minority Interest0000000000
Debt681315101935405387
Long Term Debt236701111294249
Short Term Debt457810923111138
Trade Payables571623393446604959
Others Liabilities 35101181319191823
Total Liabilities 1823435679105141162187257

Fixed Assets

Gross Block12132128253537384252
Accumulated Depreciation556794681013
Net Fixed Assets781521163131303239
CWIP 01001100000
Investments 0000000000
Inventories441071841506846150
Trade Receivables351120151839419035
Cash Equivalents 0111113123
Others Assets3468171418211630
Total Assets 1823435679105141162187257

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity -1234171-110-2-14
PBT 01222622917
Adjustment 01223269812
Changes in Working Capital -20-0-013-7-19-10-19-44
Tax Paid 0000000000
Cash Flow From Investing Activity -2-3-6-7-8-5-1-1-4-9
Capex -2-2-7-3-1-16-1-1-4-9
Net Investments 0000000000
Others 0-11-4-7110000
Cash Flow From Financing Activity 2133-8414-1725
Net Proceeds from Shares 0052-110000
Net Proceeds from Borrowing 0000-47118137
Interest Paid 0-1-2-2-2-3-4-4-5-9
Dividend Paid 0000000000
Others 2202-1017-14-128
Net Cash Flow 001-1102-211
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)9.799.6833.4633.8813.0214.594.744.7711.4213.86
ROCE (%)14.514.2324.6718.1615.920.5610.369.5313.1518.35
Asset Turnover Ratio1.341.251.281.140.881.050.920.881.291.24
PAT to CFO Conversion(x)N/AN/A348.50.25-5.50-0.33-1.27
Working Capital Days
Receivable Days456272102109629210910783
Inventory Days575763557811114816193131
Payable Days15614422329028522117819011294

Fredun Pharmaceuticals Ltd Stock News

Fredun Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Fredun Pharma on 18-May-2024 12:50 is ₹871.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 18-May-2024 12:50 the market cap of Fredun Pharma stood at ₹415.7.
The latest P/E ratio of Fredun Pharma as of 18-May-2024 12:50 is 26.61.
The latest P/B ratio of Fredun Pharma as of 18-May-2024 12:50 is 3.37.
The 52-week high of Fredun Pharma is ₹1,249 and the 52-week low is ₹650.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Fredun Pharma is ₹346.6 ( Cr.) .

About Fredun Pharmaceuticals Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.